Category Archives: Pharmaceuticals

FDA Panel Supports Novartis Version of Amgen Arthritis Drug

By unanimous FDA panel vote, Novartis AG’s (Basel CHE) Enbrel (etanercept) biosimilar was approved across all of its U.S. licenses. The panel, which gives nonbinding advice to the agency, voted… Read more »

GE Healthcare Barges into Cell-Therapy Arena with Swiss Buy; Where’s the FDA?

GE Healthcare (Little Chalfont GBR) just signaled its intention to build a $1 billion business which offers specialized manufacturing tools for an upcoming tidal wave of cell therapies by acquiring… Read more »

U.S. House Unanimously Approved Legislation to Combat Opioid Overdoes

Elsewhere, the House on Friday almost unanimously approved legislation to combat opioid overdoses after Democrats dropped their opposition to the bill at the last minute. The 407-5 vote all but assures… Read more »

Fentanyl Responsible for an Epidemic of Overdose Deaths Around the United States

Fentanyl, a powerful painkiller that a medical examiner identified as the drug that killed the superstar Prince six weeks ago, has been responsible for an epidemic of overdose deaths around… Read more »

New Type of Non-Opioid Pain Drug Seeks FDA Approval

ELI LILLY & CO. (Indianapolis IN) said it and partner Pfizer Inc. (New York City) aim to seek approval by 2018 for a new type of pain drug that could… Read more »

FDA Approves New Treatment for Opioid Addiction

Federal health officials on Thursday approved an innovative new option for Americans struggling with addiction to heroin and painkillers: a drug-oozing implant that curbs craving and withdrawal symptoms for six… Read more »

Cigna Signs “Results-Based” Deals on Costly Amgen, Sanofi Cholesterol Meds

Cigna Corp. (Bloomfield CT) signed deals that will pay the makers of two potent but pricey cholesterol-lowering treatments based on how well their customers respond to the medications, the health… Read more »

AbbVie Agrees to Buy Stemcentrx, Reports Jump in Earnings

U.S. biopharmaceutical firm AbbVie Inc. (North Chicago) on Thursday said it will acquire cancer biotech company Stemcentrx Inc. (South San Francisco) in a roughly $5.8 billion cash and stock deal that would expand… Read more »

New AbbVie Hepatitis C Regimen Shows Strong Cure Rates

Although arriving a little late to the party, AbbVie Inc. (North Chicago) is touting impressive cure rates for its new daily hep C combo as it looks to find a… Read more »